
Opinion|Videos|July 29, 2024
Melanoma Research Beyond ASCO 2024: Upcoming Advances and Insights
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the current challenges in translating clinical trial results into real-world practice for melanoma treatment? How can this process be streamlined?
- Please discuss any other data in melanoma released at ASCO 2024 that you find noteworthy to share with colleagues. (Please be prepared to discuss during the interview)
- Outside of ASCO 2024, what ongoing research efforts are you most excited for in the treatment and management of melanoma? What can we look forward to through the end of the year and beyond?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
How Effective and Safe Are GLP-1s for Weight Loss?
3
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
4
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
5













































